PUBLISHER: Grand View Research | PRODUCT CODE: 1888936
PUBLISHER: Grand View Research | PRODUCT CODE: 1888936
The global umbilical vessel catheters market size was estimated at USD 550.56 million in 2024 and is projected to reach USD 887.45 million by 2033, growing at a CAGR of 5.56% from 2025 to 2033. The industry is driven by several key factors, including the rising incidence of preterm births and the growing need for advanced neonatal intensive care worldwide. Increasing investments in healthcare infrastructure and NICU capacity have enhanced access to specialized vascular access devices for newborns.
The rising incidence of preterm births is a primary factor driving the growth of the umbilical vessel catheters industry. Preterm infants often require immediate and reliable vascular access for administering fluids, medications, and parenteral nutrition in neonatal intensive care units (NICUs). Umbilical vessel catheters (UVCs and UACs) play a crucial role in stabilizing these infants during the critical early stages of life. With increasing global preterm birth rates and improved survival outcomes, the demand for advanced, safe, and infection-resistant catheters continues to rise. Moreover, growing awareness among healthcare professionals and the expansion of neonatal care infrastructure further reinforce market growth worldwide. According to the Reproductive Health Journal, the number of preterm births remained high globally, with an estimated 13.4 million cases in 2020. According to the Centers for Disease Control and Prevention (CDC), both early and late preterm birth rates increased by 4% from 2020 to 2021 but later declined by 1%-2% from 2021 to 2022.
The growing need for advanced neonatal intensive care is a major factor driving the umbilical vessel catheters market. As the number of preterm and low-birth-weight infants continues to rise, the demand for reliable and safe vascular access solutions has increased significantly. Umbilical vessel catheters play a crucial role in delivering essential medications, fluids, and nutrition while allowing continuous monitoring of critically ill newborns. The expansion of neonatal intensive care units (NICUs) and the adoption of advanced medical technologies are further enhancing their use. In addition, the focus on improving neonatal survival rates and reducing complications is accelerating the adoption of high-performance, infection-resistant catheters across hospitals worldwide.
Technological innovations, like antimicrobial-coated catheters, are further enhancing adoption by reducing infection risks and improving patient safety. Furthermore, the growing awareness among healthcare professionals of early neonatal interventions and infection control practices continues to drive global market growth. The integration of imaging-guided insertion techniques and real-time monitoring systems is enhancing precision and reducing procedural complications. Moreover, ongoing product development by key manufacturers is expanding the availability of advanced, cost-effective solutions for neonatal care worldwide.
Global Umbilical Vessel Catheters Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global umbilical vessel catheters market report based on product, material, channel, indication/use, end use, and region: